MICHAEL SASSANO CHAIRMAN OF THE BOARD, CEO SOMAI PHARMACEUTICALS
SOMAÍ Pharmaceuticals is on the cutting edge of developing exclusive partnerships with industry leaders in alternative medicine.
Michael Sassano is the current CEO and Chairman of the Board for SOMAÍ Pharmaceuticals LTD, an Ireland-based company focused on cultivation and production of cannabinoid-containing pharmaceutical products throughout the European Union.
SOMAÍ emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system, effectively and with consistency across markets. SOMAÍ currently has offices and facilities in Ireland, Germany, Portugal, Switzerland, Greece, UK and Israel.
SOMAÍ prides themselves on harnessing the knowledge and experience that Michael brings to the table from the most established cannabis market in the world: the American West Coast. Taking with him the cultivation and extraction techniques he’s learned and the confidence gained from these dealings will give him and his company the chance to bring innovative products and ideas to citizens all over Europe.
The current focus of SOMAÍ is building scalable high out-put cultivation and extraction facilities in various strategic countries as Europe develops its market. SOMAÍ’s method of development is scalability-based, matching the pace of Europe’s cannabis industry growth. As the continent ultimately comes online, SOMAÍ will be positioned as one of the top global pharmaceutical distributors of medical-grade, EU-GMP certified cannabis.